Please login to the form below

Not currently logged in
Email:
Password:

Hansa Medical strengthens management team

Henk Doude van Troostwijk becomes vice president, commercial operations

Swedish biopharmaceutical company Hansa Medical has appointed Henk Doude van Toostwijk as its new vice president, commercial operations.

In his new role, van Troostwijk will be responsible for overseeing the firm's commercial assessments of its lead project IdeS, an orphan drug in development for organ rejection.

Goran Arvidson, president and chief executive of Hansa Medical, said: “We are very excited that Henk will engage in Hansa Medical, as we now start to prepare our commercialisation strategy for IdeS.”

Van Troostwijk brings over 20 years of sales and marketing experience in transplantation and orphan drugs, most recently as general manager of emerging markets at Raptor Pharmaceuticals.

He has also held a number of management positions at Bioenvisions, Bristol-Myers Squibb, Merck as well as serving as business unit director oncology and transplantation for Genzyme. 

27th May 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics